Drugs that contain Celecoxib

1. List of Elyxyb drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10722456 BDSI Oral composition of celecoxib for treatment of pain
May, 2036

(13 years from now)

US10799517 BDSI Oral composition of celecoxib for treatment of pain
May, 2036

(13 years from now)

US9949990 BDSI Oral composition of celecoxib for treatment of pain
May, 2036

(13 years from now)

US9795620 BDSI Oral composition of celecoxib for treatment of pain
May, 2036

(13 years from now)

US9572819 BDSI Oral composition of celecoxib for treatment of pain
May, 2036

(13 years from now)

US10376527 BDSI Oral composition of celecoxib for treatment of pain
May, 2036

(13 years from now)

Exclusivity Exclusivity Expiration
New Product (NP) May 5, 2023

Market Authorisation Date: 05 May, 2020

Treatment: Acute treatment of migraine with or without aura in adults

Dosage: SOLUTION;ORAL

More Information on Dosage

ELYXYB family patents

11

United States

4

China

3

Australia

2

Brazil

2

Canada

2

India

2

Russia

2

European Union

1

IB

1

Korea, Republic of

1

New Zealand

1

Mexico

1

EA

1

Japan

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic